TIMP1 and colonic neoplasm: TIMP-1 has been identified as a target of aberrant N-glycosylation by the action of N-acetylglucosaminyltransferase V in human WiDr colon cancer cells, and this aberrant TIMP-1 glycoform has been associated with tumor cell invasion in vitro and metastasis in vivo [125].